RFC4 and cervical squamous cell carcinoma: Zhang et al. determined the potential role of RFC4 in cervical carcinogenesis through comprehensive study of gene expression profiles; and RFC4 was proposed as a novel alternative biomarker to determine HSIL and HSIL+, as well as an independent prognostic biomarker for cervical squamous cell carcinoma (Zhang et al., 2022).